top of page

Committed to Health

About

Transforming the future of health care through innovative life science solutions and strategic partnerships.

CureOmics is dedicated to improve therapeutic and preventive options for unmet health care needs.

 

Our research is focused on the development of novel pharmaceuticals, nutraceuticals and cosmeceuticals

Petrischale

Research and Product Development

Specialising in regenerative medicine and aging, we translate and expand this expertise to develop advanced dermatological products. Our nutraceutical portfolio addresses joint health, inflammation, metabolism and gut health.

Rosa Ölblasen

1

Pharmaceuticals

OUR RESEARCH & PARTNERED PROGRAMS

Our teams’s expertise is deeply rooted in pharmaceutical sciences, where we focus on advancing our lead pipeline program. 

Alongside our in-house innovations, we partner with third-party pharmaceutical companies to co-develop and register innovative and selected generic drugs. This dual approach allows us to prioritize our own research while also expanding our impact through strategic partnerships. 

2

Neutraceuticals

OUR RESEARCH & PRODUCT PORTFOLIO

CureOmics is developing a new supplement ingredient that can support various aspects of health, particularly in aging, inflammation, and metabolic function.

In parallel, we have a portfolio of clinically validated next-generation nutraceuticals for health care and preventive care. These products are specifically formulated to support joint health, reduce inflammation, and optimize metabolism. Additionally, our nutraceuticals also target gut health, promoting a balanced microbiome and gastric function.

3

Cosmeceuticals

OUR INNOVATION & PRODUCT PORTFOLIO

Our company has built its dermatology-research around the development of an innovative and new cosmetic ingredients with the ability to counteract the age-related deterioration of skin function. Our first-to-market ingredient provides versatile formulation options, making it adaptable to a wide range of skincare products. Its mechanism of action has been clinically proven to enhance cellular function relevant for both the dermis and epidermis, ensuring holistic skin support. Through this advancement, we aim to set new standards in anti-aging skincare solutions.

We complement this innovation with a product portfolio of best-in-class clinically tested cosmetic ingredients.

Face Serum

Partnering 

Accelerating Innovation Through Strategic Alliances

CureOmics has formed strategic partnerships with corporates, CRO and CMO organisations. We are collaborating with these partners to develop innovative drug products, nutraceuticals and cosmeceuticals. These alliances enable us to leverage specialised expertise and advanced technologies, ensuring efficient and high-quality development processes. By aligning with trusted partners, we enhance our capabilities, accelerate time-to-market, and drive innovation across all of our areas of focus.

We are actively interested in partnerships. Core areas of interest for partnership are cosmetic formulations and food supplement formulations. For Pharma, our central interest is in co-development or licensing opportunities.

Please reach out to us: info@cureomics.com

Alle Hände rein

What We Stand For

Innovation, Health, Community.

CureOmics is committed to improve people's lives.

We achieve this through a dedicated focus on scientific and technological advances and translating this knowledge into innovative pharmaceuticals, nutraceuticals and cosmeceuticals.

We believe in the power of community and are committed to building trust-based, long-lasting relationships with our partners, clients, employees, vendors and shareholders. 

Wissenschaft
DNA

CureOmics in Numbers

75

Employees

$100

In Investments

224

Partners Worldwide

15

Publications

25

Ongoing Research Programs

Join Our Team

We’re looking for highly-motivated and talented people to join our innovative team. Submit your application today.

New job opening coming soon

Zug, CH

News

CureOmics joins the CPHI Europe

 

Milan, Italy
October 2024

We will be attending the EMBO Symposium

The ageing genome: from mechanism to disease

Heidelberg, Germany
June 2025

CureOmics joins VitaFood Europe

 

 

Barcelona, Spain
May 2025

Join The CureOmics Newsletter

Be the first to receive the latest news and updates.

bottom of page